NF-kappaB activation contributes to anthracycline resistance pathway in human ovarian carcinoma cell line A2780.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  International Journal of Oncology

• Publication date

  2005-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJO.27.3.799PMID 16077931
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B.

  2004cited by this paper
• Constitutive nuclear factor-kappa B mRNA, protein overexpression and enhanced DNA-binding activity in thymidylate synthase inhibitor-resistant tumour cells

  2003cited by this paper
• Modulation of NF-kappaB activity by exchange of dimers.

  2003cited by this paper
• Inhibition of inducible NF-kappaB activity reduces chemoresistance to 5-fluorouracil in human stomach cancer cell line.

  2003cited by this paper
• Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death.

  2003cited by this paper
• Nuclear factor‐κB, induced in human carcinoma cell line A2780 by the new anthracycline men 10755, is devoid of transcriptional activity

  2002cited by this paper
• Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines.

  2002cited by this paper
• cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways.

  2001cited by this paper
• c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells.

  2001cited by this paper
• A comparative study of cellular and molecular pharmacology of doxorubicin and MEN 10755, a disaccharide analogue.

  2001cited by this paper
• Inducible chemoresistance to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothe cin (CPT-11) in colorectal cancer cells and a xenograft model is overcome by inhibition of nuclear factor-kappaB activation.

  2000cited by this paper
• Pleiotropic resistance to DNA-interactive drugs is associated with increased expression of genes involved in DNA replication, repair, and stress response.

  2000cited by this paper
• An informatics approach identifying markers of chemosensitivity in human cancer cell lines.

  2000cited by this paper
• Multiple signals converging on NF-kappaB.

  1999cited by this paper
• Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB

  1999cited by this paper
• Control of apoptosis by Rel/NF-kappaB transcription factors.

  1999cited by this paper
• Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells.

  1998cited by this paper
• Clinical significance of the increased multidrug resistance-associated protein (MRP) gene expression in patients with primary breast cancer.

  1998cited by this paper
• Possible role of the multidrug resistance‐associated protein (MRP) in chemoresistance of human melanoma cells

  1997cited by this paper
• Proteasome regulation of Fas ligand cytotoxicity

  1997cited by this paper
• Doxorubicin disaccharide analogue: apoptosis-related improvement of efficacy in vivo.

  1997cited by this paper
• Characterization of novel human leukemic cell lines selected for resistance to merbarone, a catalytic inhibitor of DNA topoisomerase II.

  1996cited by this paper
• Differential transcriptional activation in vitro by NF-kappa B/Rel proteins.

  1995cited by this paper
• MRP gene overexpression in a human doxorubicin‐resistant SCLC cell line: Alterations in cellular pharmacokinetics and in pattern of cross‐resistance

  1995cited by this paper
• Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.

  1994cited by this paper
• Biochemistry of multidrug resistance mediated by the multidrug transporter.

  1993cited by this paper
• Characterization of a topoisomerase II gene rearrangement in a human small-cell lung cancer cell line.

  1992cited by this paper
• A novel NF-kappa B element within exon 1 of the murine c-myc gene.

  1992cited by this paper
• New colorimetric cytotoxicity assay for anticancer-drug screening.

  1990cited by this paper
• The biochemistry of P-glycoprotein-mediated multidrug resistance.

  1989cited by this paper
• I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

  1988cited by this paper

• Exploring the Impact of NF- KB1 Gene Polymorphism

  2023cites this paper
• Evaluation of Changes in NFKB Gene Expression Following Epstein-barr Virus and Its Participation in the Half-life of Patients With Acute Epstein-Barr Positive Lymphoblastic Leukemia

  2021cites this paper
• Effects of Induced Exosomes from Endometrial Cancer Cells on Tumor Activity in the Presence of Aurea helianthus Extract

  2021cites this paper
• Modulation of Tumor Microenvironment through Aurea Helianthus Extract and Induced Exosomes

  2020cites this paper
• Triptolide sensitizes oral squamous cell carcinoma cell to cisplatinvia inhibition of NF-κB activity in vitro

  2016cites this paper
• NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)

  2013cites this paper
• Protective Effect of Caffeic Acid on Paclitaxel Induced Anti-Proliferation and Apoptosis of Lung Cancer Cells Involves NF-κB Pathway

  2012cites this paper
• A Functional Insertion/Deletion Polymorphism (-94 ins/del ATTG) in the Promoter Region of the NFKB1 Gene Is Related to the Risk of Renal Cell Carcinoma

  2012cites this paper
• NFKB1 Insertion/Deletion Promoter Polymorphism Increases the Risk of Advanced Ovarian Cancer in a Chinese Population

  2011cites this paper
• Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy.

  2010cites this paper
• Synthetic DNA-Targeted Chemotherapeutic Agents And Related Tumor-Activated Prodrugs

  2010cites this paper
• Elevation of cyclic AMP causes an imbalance between NF‐κB and p53 in NALM‐6 cells treated by doxorubicin

  2010cites this paper
• Effects of cardiotoxin III on NF-kappaB function, proliferation, and apoptosis in human breast MCF-7 cancer cells.

  2009cites this paper
• Imatinib resistance in multidrug-resistant K562 human leukemic cells.

  2009cites this paper
• No Association of the NF-κB1 −94INS/Delattg Promoter Polymorphism with Relapse-Free and Overall Survival in Patients with Squamous Cell Carcinomas of the Head and Neck Region

  2008cites this paper
• Cellular mechanisms of resistance to anthracyclines and taxanes in cancer: intrinsic and acquired.

  2008cites this paper
• Targeting Transcription Factors with Decoy Oligonucleotides: Modulation of the Expression of Genes Involved in Chemotherapy Resistance of Tumor Cells

  2008cites this paper
• Cancer Therapy with Metronomically Scheduled Cyclophosphamide: Experimental Modalities within GDEPT and Tumor Escape Mechanisms

  2007cites this paper
• Enhancement of chemotherapeutic efficacy by small molecule inhibition of NF-kappaB and checkpoint kinases.

  2007cites this paper
• NF-kappa B as a target for cancer therapy.

  2007cites this paper
• Downregulation of NF-kappaB activation in a H4IIE transfectant insensitive to doxorubicin-induced apoptosis.

  2007cites this paper
• NF-κB as a target for cancer therapy

  2007cites this paper
• Inhibition of the Canonical IKK/NFκB Pathway Sensitizes Human Cancer Cells to Doxorubicin

  2007cites this paper
• Correlation of TLK1B in elevation and recurrence in doxorubicin-treated breast cancer patients with high eIF4E overexpression.

  2007cites this paper
• Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin.

  2007cites this paper
• Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells.

  2006cites this paper
• No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia

  2006cites this paper
• Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors.

  2006cites this paper
• Glycogen synthase kinase-3β positively regulates the proliferation of human ovarian cancer cells

  2006cites this paper
• UPR activation alters chemosensitivity of tumor cells

  2006cites this paper
• Synthetic DNA‐Targeted Chemotherapeutic Agents And Related Tumor‐Activated Prodrugs

  year unknowncites this paper